文献速递胸部肿瘤

利用机器学习技术检测癌症登记数据中的复发:基于德国肺癌数据的多登记处验证研究

Leveraging machine-learning techniques to detect recurrences in cancer registry data: A multi-registry validation study using German lung cancer data.
PubMed 文献 · Eur J Cancer · 2025-07-05

该研究利用汉堡癌症登记处的肺癌(ICD-10:C34)数据开发机器学习模型,用于识别和分类癌症复发与进展,并在德国另外五个癌症登记处的数据上验证其预测性能。模型在测试数据集中的曲线下面积(AUC)范围为0.74至0.99,分类准确性与经验丰富的人工标注者相当。研究结论认为机器学习可增强癌症登记数据的解读,为大规模分析提供可靠手段。

要点

  • 基于汉堡癌症登记处肺癌数据开发机器学习模型,用于识别和分类复发与进展。
  • 模型在五个德国癌症登记处验证,AUC范围为0.74至0.99。
  • 模型分类准确性与经验丰富的人工标注者相当。

核心结论

  • 机器学习在增强癌症登记数据解读方面具有潜力,该算法能可靠识别复发和进展,弥补报告不完整造成的缺口。

研究设计与样本

  • 研究利用汉堡癌症登记处的肺癌(ICD-10:C34)数据开发机器学习模型,并创建标准化指标数据集以确保互操作性。
  • 模型预测性能在德国另外五个癌症登记处的数据上进行验证,最终选用基于直方图的梯度提升决策树集成模型。

主要发现

  • 模型在测试数据集中的曲线下面积(AUC)范围为0.74至0.99,显示其稳健性和泛化能力。
  • 模型分类准确性与经验丰富的人工标注者相当,确保其用于大规模分析的可靠性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cancer recurrence and progression, once seen as markers of poor prognosis, are now considered manageable aspects of long-term care. Advances in treatment have extended survival, emphasizing the need for representative epidemiological information. Population-based cancer registries are essential in this respect. However, tracking treatment outcomes and accurately distinguishing recurrences from progressions remain challenging due to incomplete follow-up data. To address this aiming at meaningful cancer registry data analyses, we employed machine learning (ML) for precise classification, surpassing traditional clinical assumptions. METHODS: We developed a ML model to identify and classify cancer recurrence and progression using lung cancer (ICD-10: C34) data from the Hamburg Cancer Registry. To ensure interoperability, we created a standardized indicator dataset. The model's predictive performance was validated using data from five additional German cancer registries. After extensive evaluation, a histogram-based gradient-boosted decision tree ensemble was chosen for its high accuracy and adaptability. RESULTS: The model demonstrated strong predictive performance, with areas under the curve (AUC) ranging from 0.74 to 0.99 across test datasets, highlighting its robustness and generalizability. Its classification accuracy was comparable to experienced human annotators, ensuring reliability for large-scale analysis. CONCLUSION: This study highlights the potential of ML in enhancing cancer registry data interpretation. By reliably identifying recurrences and progressions, our algorithm addresses gaps caused by incomplete reporting. The established framework provides a scalable approach for integrating AI-driven insights into cancer research, improving registry-based outcome analyses, and supporting advancements in cancer epidemiology.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Kusche H, Gundler C, Johanns O, et al. Leveraging machine-learning techniques to detect recurrences in cancer registry data: A multi-registry validation study using German lung cancer data. Eur J Cancer. 2025. PMID: 40674828. doi:10.1016/j.ejca.2025.115604

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。